Interestingly, in patients with chronic liver disease, serum CXCL10 levels, but not hepatic CXCL10 mRNA levels, were positively correlated with portal hypertension, fibrosis stage, and disease progression [50,51]. Here, CXCL10 is linked to portal hypertension.